United States News All stories

Novartis (NYSE:NVS) has agreed to acquire Myricx Bio, a U.K.-based biotechnology company, in a transaction valued at up to $1.5 billion.

Skillsoft (NYSE:SKIL) announced it completed the sale of its Global Knowledge training business to an affiliate of Enduring Ventures to create a simplified product portfolio.

Descartes Systems Group (NASDAQ:DSGX) said it has acquired Drivin, a Latin American last-mile delivery management platform, in a cash transaction worth approximately $30 million.

TG Therapeutics (NASDAQ:TGTX) has begun a Phase 2, open-label, single-arm, multicenter study of BRIUMVI (ublituximab-xiiy) in adults with treatment-resistant schizophrenia.

Sky, the UK-based television and telecom provider owned by Comcast (NASDAQ:CMCSA), has agreed to acquire ITV’s media and entertainment division in a deal valued at up to £1.6 billion.

Incyte (NASDAQ:INCY) said it has completed the acquisition of Vega Therapeutics, a subsidiary of Star Therapeutics, in a transaction valued at $1.25 billion upfront.

Lockheed Martin (NYSE:LMT) has signed a definitive agreement to acquire Ultra Maritime, a specialist in undersea and anti-submarine warfare systems, in a transaction valued at $3.45 billion.

ZIM (NYSE:ZIM) announced an operational update regarding its pending business combination, confirming it remains in compliance with its merger agreement alongside Hapag-Lloyd.

The Middleby Corporation (NASDAQ:MIDD) said it has completed the previously announced spin-off of its Food Processing business into a new standalone company, Midera Food Processing.

Antelope Enterprise Holdings (NASDAQ:AEHL) reported unaudited results for the six months ended March 31, 2026, showing revenue of approximately $29.9 million.

Invivyd (NASDAQ:IVVD) announced it received formal notification from the FDA that the Emergency Use Authorization for its monoclonal antibody treatment PEMGARDA will terminate on June 29, 2027.

Innovative Eyewear (NASDAQ:LUCY) reported preliminary unaudited net sales of approximately $0.99 million for Q2 2026, representing a year-over-year increase of about 71%.

Ondas Holdings (NASDAQ:ONDS) said it has entered into an agreement to acquire DZYNE Technologies in a transaction valued at approximately $875.8 million in cash and stock.

Iridium (NASDAQ:IRDM) announced it completed the acquisition of Aireon to combine global satellite communications with space-based air traffic surveillance.

easyJet said it has agreed in principle to a £5.5 billion ($7.3 billion) cash offer from U.S. investment firm Castlelake after rejecting four earlier proposals.

Agenus (NASDAQ:AGEN) reported updated Phase 1b clinical data for its botensilimab (BOT) and balstilimab (BAL) combination in patients with refractory microsatellite-stable metastatic colorectal cancer without active liver metastases.

Solaris Energy Infrastructure (NYSE:SEI) announced it executed an agreement to acquire Global Energy Services Alliance to scale up its full-cycle power generation solutions.

Ceva (NASDAQ:CEVA) announced a landmark licensing agreement with a major U.S. software and AI platform company to support a custom AI silicon program aimed at next-generation intelligent computing devices.

Ionis Pharmaceuticals (NASDAQ:IONS) announced it completed patient enrollment in the pivotal pediatric cohort of its global Phase 3 REVEAL clinical study evaluating its investigational RNA-targeted medicine, obudanersen.

Pharvaris (NASDAQ:PHVS) announced the FDA accepted its regulatory application for its 20 mg hereditary angioedema on-demand treatment capsule.

Maximus (NYSE:MMS) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.33 per share to reward equity investors.

Lindsay (NYSE:LNN) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.38 per share.

AtaiBeckley (NASDAQ:ATAI) announced it completed dosing the final patient in its Phase 2b Elumina clinical trial evaluating VLS-01 for treatment-resistant depression.

AEVEX (NYSE:AVEX) announced it secured a $17.5 million follow-on defense contract under its Global Solutions business segment to continue delivering critical intelligence services.